Tampa, FL – The H. Lee Moffitt Cancer Center & Research Institute congratulates Srikumar Chellappan, Ph.D., a member of the Drug Discovery program, for being elected by his peers as Scientist of the Year 2007.
Chellappan graduated from the University of Kerala, India, in 1981 with a degree in zoology. He received hisPh.D. in biochemistry from the Indian Institute of Science, Bangalore, India, in 1987 and hispost-doctoral degree in molecular biology from Duke University Medical Center in 1991.
Since arriving at Moffitt in 2001, Chellappan has established himself as a productive and innovative scientist. He has more than 40 peer reviewed publications, including a recent publication in PNAS where Chellappan and his colleagues determined that nicotine affects the efficacy of chemotherapeutic drugs. He currently has two active grants and is a project leader on the recently funded Drug Discovery grant. His major research interest is to understand the mechanisms by which extra-cellular signals regulate the cell cycle machinery, and how a loss of this regulation leads to oncogenesis.
Chellappan will be recognized in June at a Moffitt reception to celebrate this honor.
About H. Lee Moffitt Cancer Center & Research Institute
Located in Tampa, Florida on the University of South Florida campus, H. Lee Moffitt Cancer Center & Research Institute (www.moffitt.org) is the only Florida-based cancer center with the NCI designation as a Comprehensive Cancer Center for its excellence in research and contributions to clinical trials, prevention and cancer control. Moffitt currently has 15 affiliates in Florida, one in Georgia and two in Puerto Rico. Additionally, Moffitt is a member of the National Comprehensive Cancer Network, a prestigious alliance of the country’s leading cancer centers, and is listed in U.S. News & World Report as one of America’s Best Hospitals for cancer. Moffitt’s sole mission is to contribute to the prevention and cure of cancer.